GLA-SE

glucopyranosyl lipid adjuvant in stable emulsion

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GLA-SE, covering 2017-08-17 to 2018-06-13. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma [Phase 1]